CYP 2.33% 21.0¢ cynata therapeutics limited

Ann: Patient Enrolment Opens in COVID-19 Clinical Trial, page-25

  1. 976 Posts.
    lightbulb Created with Sketch. 148
    What would put a big catalyst on the SP is an announcement on the MEND trial expanding to other states e.g. Victoria which I am hoping the company is actively pursuing (as mentioned in their various presentation). The readouts would be a lot sooner. In addition, I think we are forgetting that CYP has a close working relationship with Fujifilm and the Covid numbers in Japan are increasing. It would not be surprising if they announce a separate trial over there.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.